MET and neoplasm: Since the juxtamembrane domain regulates ligand-dependent MET internalization as a consequence Y1003 phosphorylation leading to MET ubiquitination and degradation [13], the MET-T1010I SNP in the juxtamembrane domains may contribute to MET accumulation at the cell surface and persistent pathway activation contributing to effects on tumor pathophysiology [13].